Medivation Elects Dawn Graham to Board of Directors

Medivation (NASDAQ: MDVN ) today announced that Dawn Graham has been elected to the Company's Board of Directors. Ms. Graham joins Medivation following a 23-year career in pharmaceutical commercial leadership positions at Merck & Co. Inc., from which she retired in 2011 as President of Europe and Canada. "Dawn's